Biocon's Bengaluru drug manufacturing facility gets 'Voluntary Action Indicated' classification

Biocon Biologics' drug substance facility in Bengaluru has been classified as Voluntary Action Indicated (VAI) by the USFDA. This classification means that while some objectionable conditions were found during the inspection, the agency is not pursuing regulatory action.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mD6zjSv
via IFTTT